Research Grade Anti-PD-L1 & TGF-Beta Bispecific Antibody (Tqb2858)Anti-PD-L1 & TGF-Beta Bispecific Antibody (Tqb2858) ( HF977116 ) is a research-grade recombinant antibody targeting CD1 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Bispecific Antibodies | | Target | Programmed cell death 1 ligand 1, PD-L1, PDCD1 ligand 1, Programmed death ligand 1, hPD-L1, B7 homolog 1, B7-H1, CD274, CD274, Transforming growth factor beta-1 proprotein, Latency-associated peptide, LAP, Transforming growth factor beta-1, TGF-beta-1, TGFB1 | | Accession | Q9NZQ7 & P01137 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-15524-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-PD-L1 & TGF-Beta Bispecific Antibody (Tqb2858). Примечание: |
|